Carole Sourbier

Title: Carole Sourbier: Innovator in HIV and HTLV Treatment

Introduction

Carole Sourbier is a notable inventor based in Rockville, MD (US). She has made significant contributions to the field of medical research, particularly in the treatment of patients infected with HIV and HTLV. Her innovative approach has the potential to impact many lives.

Latest Patents

Carole Sourbier holds 1 patent for her work titled "Methods of treating patients infected with HIV and HTLV." This patent discloses a method of activating protein kinase C theta (PKCθ) in an HIV or HTLV infected animal. The method involves administering an effective amount of a compound of formula (I), or an epimer thereof. The diseases associated with PKCθ include HIV1 infection, AIDS, HTLV infection, and adult T cell leukemia/lymphoma.

Career Highlights

Carole Sourbier is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this prestigious institution underscores her commitment to advancing medical science and improving patient outcomes.

Collaborations

Throughout her career, Carole has collaborated with esteemed colleagues, including Leonard M Neckers and Jane B Neckers. These partnerships have fostered a collaborative environment that enhances research and innovation.

Conclusion

Carole Sourbier's contributions to the field of HIV and HTLV treatment exemplify her dedication to medical research and innovation. Her work continues to pave the way for advancements in healthcare.